Valeant's Permax No Longer Permitted In The U.S. For Parkinson's Disease
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA announces voluntary withdrawal of the pergolide brand and two generics due to high rates of cardiac valvulopathy.